Showing results (881-890 of 988) with videos related to
Sort By:
Pageof 99
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.Cell|July 3, 2003
A panoramic view of yeast noncoding RNA processingWen Tao Peng, Mark D Robinson, Sanie Mnaimneh, et al.Clinical Genitourinary Cancer|August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry ExperienceBrian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 17, 2025
Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population-An evaluation of the recruitment effortYue Ma, Maria C Mora Pinzon, William R Buckingham, et al.Arthritis and Rheumatism|February 13, 2013
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitisMaria Apel, Steffen Uebe, John Bowes, et al.Plos One|May 24, 2007
Global genetic population structure of Bacillus anthracisMatthew N Van Ert, W Ryan Easterday, Lynn Y Huynh, et al.Nature Genetics|October 19, 2010
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisUlrike Hüffmeier, Steffen Uebe, Arif B Ekici, et al.Cancer|March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.European Journal of Cancer (Oxford, England : 1990)|October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgeryEvan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.Gut|February 26, 2009
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signallingG Trynka, A Zhernakova, J Romanos, et al.Pageof 99